Abstract
Protein kinase B (AKT) PI3K / AKT / mTOR signaling pathways play a crucial role in modulating cell survival, proliferation, metastasis, metabolism, angiogenesis, and apoptosis. The AKT family consists of three isoforms: AKT1, AKT2, and AKT3. Moreover, it has high sequence homology in the kinase domain and has similar substrate specificity to other members of AGC protein kinase. Recent studies have shown that AKT signals disappear in some tumors. Overexpression and activation of AKT are not sufficient to induce the phenotype of malignant tumors. However, many studies have shown the importance of AKT in carcinogenesis including, breast and prostate cancers, second and third global cancer burden, respectively, in terms of incidence and death. Inhibition of AKT signaling may be beneficial in terms of therapeutic use and understanding of the function of AKT. To date, limited numbers of AKT inhibitors have been identified, and none are strongly selective for AKT isoforms. In this regard, we discussed the current insight of AKT inhibitors in drug development, protein structure, and mechanism as well as the role of AKT in the development of drug targets for breast cancer and prostate cancer.
Keywords: AKT, AKTinhibitors, breast cancer, prostate cancer, AKTsignaling, PI3K.
Current Molecular Pharmacology
Title:Overview of Protein Kinase B Enzyme: A Potential Target for Breast and Prostate Cancer
Volume: 14
Author(s): Rajesh Basnet*Buddha B. Basnet
Affiliation:
- State Key Laboratory of Respiratory Disease, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou,China
Keywords: AKT, AKTinhibitors, breast cancer, prostate cancer, AKTsignaling, PI3K.
Abstract: Protein kinase B (AKT) PI3K / AKT / mTOR signaling pathways play a crucial role in modulating cell survival, proliferation, metastasis, metabolism, angiogenesis, and apoptosis. The AKT family consists of three isoforms: AKT1, AKT2, and AKT3. Moreover, it has high sequence homology in the kinase domain and has similar substrate specificity to other members of AGC protein kinase. Recent studies have shown that AKT signals disappear in some tumors. Overexpression and activation of AKT are not sufficient to induce the phenotype of malignant tumors. However, many studies have shown the importance of AKT in carcinogenesis including, breast and prostate cancers, second and third global cancer burden, respectively, in terms of incidence and death. Inhibition of AKT signaling may be beneficial in terms of therapeutic use and understanding of the function of AKT. To date, limited numbers of AKT inhibitors have been identified, and none are strongly selective for AKT isoforms. In this regard, we discussed the current insight of AKT inhibitors in drug development, protein structure, and mechanism as well as the role of AKT in the development of drug targets for breast cancer and prostate cancer.
Export Options
About this article
Cite this article as:
Basnet Rajesh *, Basnet B. Buddha , Overview of Protein Kinase B Enzyme: A Potential Target for Breast and Prostate Cancer, Current Molecular Pharmacology 2021; 14 (4) . https://dx.doi.org/10.2174/1874467213999201027221759
DOI https://dx.doi.org/10.2174/1874467213999201027221759 |
Print ISSN 1874-4672 |
Publisher Name Bentham Science Publisher |
Online ISSN 1874-4702 |
Call for Papers in Thematic Issues
Common mechanisms underpinning neurodevelopmental disorders and psychiatric diseases
A growing number of large-scale epidemiologic studies has strongly suggested that common mechanisms may be shared by aberrant brain development and psychiatric disorders. There is now an appreciation of synergic roles of genetic variants and environmental stress which profoundly affect the genome integrity and reshape brain development. This can lead ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Melanogenesis Inhibitors: Strategies for Searching for and Evaluation of Active Compounds
Current Medicinal Chemistry Current Limitations in the Treatment of Parkinson’s and Alzheimer’s Diseases: State-of-the-Art and Future Perspective of Polymeric Carriers
Current Medicinal Chemistry Mutagenic Approaches to Modifying Gap Junction Phenotype
Current Drug Targets Gemini Surfactant Based Carriers in Gene and Drug Delivery
Current Medicinal Chemistry Applications of Nanosystems to Anticancer Drug Therapy (Part I. Nanogels, Nanospheres, Nanocapsules)
Recent Patents on Anti-Cancer Drug Discovery The Role of Anti-Inflammatory Drugs in Respiratory Diseases - Pirfenidone, Penicillamine, Chloroquine and Chlorambucil
Current Respiratory Medicine Reviews Synthesis of <sup>225</sup>Ac-PSMA-617 for Preclinical Use
Current Radiopharmaceuticals Scorpion Extracts Inhibit Tumor Growth in Esophageal Cancer and Lung Adenocarcinoma
Current Signal Transduction Therapy Magnetic Resonance Contrast Media Sensing In Vivo Molecular Imaging Agents: An Overview
Current Radiopharmaceuticals Roles of p97-Associated Deubiquitinases in Protein Quality Control at the Endoplasmic Reticulum
Current Protein & Peptide Science Induced Pluripotent Stem Cells as a Model for Accelerated Patient- and Disease-specific Drug Discovery
Current Medicinal Chemistry Inhibition of Transcription Factors by Plant-Derived Compounds and their Implications in Inflammation and Cancer
Current Pharmaceutical Design Defective HIF Signaling Pathway and Brain Response to Hypoxia in Neurodegenerative Diseases: Not an “Iffy” Question!
Current Pharmaceutical Design Thalidomide Analogues as Anticancer Drugs
Recent Patents on Anti-Cancer Drug Discovery Prospects of Non-Coding Elements in Genomic DNA Based Gene Therapy
Current Gene Therapy Development of Novel Nano Niosomes As Drug Delivery System of <i>Spermacoce hispida</i> Extract and <i>In Vitro</i> Antituberculosis Activity
Current Nanomaterials Efficacy of Loteprednol Etabonate Drug Delivery System in Suppression of in vitro Retinal Pigment Epithelium Activation
Pharmaceutical Nanotechnology Herbal Compounds and Toxins Modulating TRP Channels
Current Neuropharmacology Editorial (Thematic Issue: Therapeutic Applications of Advanced Drug Delivery Systems)
Current Pharmaceutical Design Phosphoinositide-3-kinases as the Novel Therapeutic Targets for the Inflammatory Diseases: Current and Future Perspectives
Current Drug Targets